What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Chlamydiosis in Birds: Clinical Presentation and Advanced Diagnostic Methods

Introduction

Chlamydiosis, caused by the obligate intracellular bacterium Chlamydia psittaci, is a systemic and often fatal disease of birds. It is a significant concern in both companion avian medicine (psittacosis) and commercial poultry production (ornithosis). The pathogen is characterized by a biphasic life cycle involving infectious elementary bodies (EBs) and metabolically active reticulate bodies (RBs). This review details the clinical presentation across avian species, the biophysical principles of advanced diagnostic methods, and current therapeutic strategies with a focus on doxycycline.

Etiology and Pathogenesis

Chlamydia psittaci is a Gram-negative bacterium with a unique developmental cycle. The infectious EB (0.2 to 0.3 micrometers) is metabolically inert and resistant to environmental degradation. Upon attachment and entry into host epithelial cells, typically via clathrin-mediated endocytosis, the EB differentiates into the larger RB (0.5 to 1.0 micrometer). The RB replicates within a membrane-bound vacuole termed an inclusion. Following multiple rounds of binary fission, RBs asynchronously differentiate back into EBs, which are released upon host cell lysis to infect adjacent cells [1, 2].

The organism possesses a type III secretion system (T3SS) that injects effector proteins into the host cytoplasm, modulating host cell signaling, inhibiting apoptosis, and facilitating nutrient acquisition [3]. The major outer membrane protein (MOMP) is a key immunogen and target for serological assays. Lipopolysaccharide (LPS) is a potent endotoxin that contributes to the inflammatory response [4].

Clinical Presentation

Clinical signs vary markedly depending on the avian species, age, immune status, and the virulence of the C. psittaci strain. Infections can be acute, subacute, or chronic, with latent carriers capable of shedding organisms intermittently under stress.

Psittacines (Pet Birds)

In psittacines (parrots, cockatiels, budgerigars), the disease is often referred to as psittacosis. Clinical signs are predominantly respiratory and gastrointestinal.

Acute Disease:

Anorexia and lethargy.
Dyspnea, tail bobbing, and rales.
Conjunctivitis with serous to mucopurulent ocular discharge.
Sinusitis and rhinitis.
Biliverdinuria (green-tinged urine) indicating hepatic involvement.
Diarrhea, often with undigested food.
Sudden death without premonitory signs in highly susceptible species such as cockatiels [5, 6].

Chronic Disease:

Weight loss and poor feather condition.
Chronic respiratory signs.
Hepatomegaly and splenomegaly detectable on radiography.
Neurologic signs including tremors, ataxia, and opisthotonos, particularly in budgerigars [7].

Poultry (Turkeys, Ducks, Chickens)

In poultry, the disease is termed ornithosis. Turkeys are highly susceptible, with mortality rates reaching 30% in severe outbreaks. Ducks are also commonly affected, while chickens are generally more resistant but can serve as subclinical carriers [8].

Turkeys:

Severe respiratory distress, sinusitis, and conjunctivitis.
Anorexia, fever, and a sharp drop in egg production.
Greenish-yellow diarrhea.
Cachexia and death within 1 to 3 weeks [9].

Ducks:

Conjunctivitis and rhinitis.
Severe sinusitis with swelling of the infraorbital sinuses.
Incoordination and tremors.
Anorexia and weight loss [10].

Chickens:

Often subclinical.
Mild respiratory signs and a slight decrease in egg production.
Can act as a reservoir for infection in mixed flocks [11].

Other Avian Species

Pigeons frequently carry C. psittaci asymptomatically but can develop respiratory disease and diarrhea. Raptors and wild waterfowl are also susceptible, with clinical signs mirroring those in psittacines and poultry [12].

Diagnostic Methods

Accurate diagnosis requires a combination of clinical assessment, hematology, serology, and molecular detection. The choice of assay depends on the clinical context, the species, and the laboratory capabilities.

Hematology and Clinical Chemistry

Hematological changes are non-specific but supportive. A complete blood count often reveals leukocytosis with heterophilia and monocytosis. Thrombocytopenia may be observed in severe cases. Clinical chemistry frequently shows elevated liver enzymes, including aspartate aminotransferase (AST) and bile acids, reflecting hepatic necrosis. Hyperglobulinemia is common in chronic infections [13].

Antigen Detection

Immunohistochemistry (IHC): IHC uses monoclonal or polyclonal antibodies directed against C. psittaci LPS or MOMP to detect antigen in formalin-fixed, paraffin-embedded tissues. This method is valuable for postmortem diagnosis and can localize antigen within lesions. Sensitivity is moderate and depends on antigen load and tissue preservation [14].

Enzyme-Linked Immunosorbent Assay (ELISA) for Antigen: Commercial ELISA kits detect Chlamydia LPS in swab samples (conjunctival, choanal, cloacal). These assays are rapid and easy to perform but have lower sensitivity compared to PCR. Cross-reactivity with other Chlamydiaceae species can occur. The assay is best used as a screening tool in flocks with high prevalence [15].

Serology

Serological tests detect antibodies against C. psittaci. They are useful for flock screening and identifying past exposure but are less reliable for diagnosing active infection due to the persistence of antibodies.

Complement Fixation Test (CFT): The CFT is a traditional method that detects antibodies against the group-specific LPS antigen. It is relatively insensitive and can be affected by anticomplementary factors in avian sera. It has largely been replaced by ELISA [16].

ELISA for Antibody Detection: Commercial ELISA kits using MOMP or LPS antigens are now standard. They offer higher sensitivity and specificity than CFT. A positive result indicates exposure but not necessarily active infection. Paired serology (acute and convalescent sera) showing a four-fold rise in titer is more indicative of recent infection [17].

Elementary Body Agglutination (EBA): The EBA test detects IgM antibodies and can indicate recent or active infection. It is less commonly used due to variability in antigen preparation [18].

Molecular Diagnostics

Nucleic acid amplification tests (NAATs) are the gold standard for diagnosing active C. psittaci infection due to their high sensitivity and specificity.

Conventional Polymerase Chain Reaction (PCR): Conventional PCR targets conserved genes such as the ompA gene (encoding MOMP) or the 16S rRNA gene. It can detect very low levels of bacterial DNA. Post-amplification steps (gel electrophoresis) are required, increasing turnaround time and risk of contamination [19].

Real-Time PCR (qPCR): Real-time PCR is the preferred method for clinical diagnosis. It uses fluorescent probes (e.g., TaqMan) to monitor amplification in real time, allowing for quantification of bacterial load. The ompA gene is a common target. qPCR is highly sensitive (detecting fewer than 10 genome copies per reaction) and specific. It can differentiate C. psittaci from other Chlamydiaceae species. The use of an internal control (e.g., a synthetic DNA sequence or a host gene) is essential to monitor for PCR inhibition [20, 21].

Genotyping and Sequencing: Sequencing of the ompA gene allows for genotyping of C. psittaci strains. There are at least 15 known genotypes (A through F, E/B, and others) that correlate with host species and virulence. Genotype A is most common in psittacines, genotype B in pigeons, and genotype D in turkeys. Genotyping is important for epidemiological investigations and understanding host range [22, 23].

Loop-Mediated Isothermal Amplification (LAMP): LAMP is an isothermal amplification method that can be performed with minimal equipment. It targets the ompA gene and provides results in under one hour. Sensitivity is comparable to conventional PCR. LAMP is suitable for point-of-care testing in field settings [24].

Diagnostic Algorithm

The following Mermaid diagram outlines a diagnostic decision tree for a bird with suspected chlamydiosis.

flowchart TD
    A[Clinical Signs: Respiratory, Ocular, GI], > B{Collect Samples}
    B, > C[Conjunctival, Choanal, Cloacal Swabs]
    B, > D[Blood (Serum)]
    B, > E[Tissue (Necropsy)]
    C, > F{Real-Time PCR}
    F, > G[Positive: Active Infection]
    F, > H[Negative: Consider Low Shedding or False Negative]
    H, > I[Repeat PCR or Test Other Sites]
    D, > J{Serology (ELISA)}
    J, > K[Positive: Past Exposure or Active Infection]
    J, > L[Negative: No Exposure or Early Infection]
    K, > M[Paired Serology: 4-fold Rise = Recent Infection]
    E, > N[Immunohistochemistry]
    N, > O[Positive: Confirm Tissue Infection]
    N, > P[Negative: Consider Other Etiologies]
    G, > Q[Initiate Doxycycline Treatment]
    Q, > R[Monitor Clinical Response and Repeat PCR]

Treatment

Doxycycline is the drug of choice for treating chlamydiosis in birds. It is a bacteriostatic tetracycline that inhibits protein synthesis by binding to the 30S ribosomal subunit.

Doxycycline Formulations and Dosing

Oral Doxycycline: Doxycycline hyclate or doxycycline calcium syrup is administered orally. The dose for psittacines is typically 25 to 50 mg/kg orally once daily for 45 days. Medicated feed or water is used for flock treatment in poultry. Doxycycline in drinking water at 200 to 400 mg/L for 21 days is common for turkeys and ducks [25, 26].

Injectable Doxycycline: Doxycycline can be administered intramuscularly or intravenously. A long-acting formulation (doxycycline hyclate in a polyethylene glycol base) is available for use in psittacines at 75 to 100 mg/kg intramuscularly every 5 to 7 days for a total of 4 to 5 injections. This regimen reduces handling stress [27].

Important Considerations:

Treatment duration must be at least 45 days for psittacines to ensure clearance of the organism. Shorter courses may lead to relapse.
Doxycycline is nephrotoxic in some species, particularly African grey parrots. Renal function should be monitored.
The drug is contraindicated in growing birds due to potential bone and tooth discoloration.
Probiotics may be administered to mitigate gastrointestinal dysbiosis [28].

Supportive Care

Supportive care is critical. This includes fluid therapy, nutritional support (e.g., hand-feeding formulas), and treatment of secondary infections. Non-steroidal anti-inflammatory drugs (NSAIDs) may be used to reduce inflammation. Severely affected birds should be hospitalized in isolation [29].

Prevention and Biosecurity

Prevention relies on strict biosecurity. New birds should be quarantined for a minimum of 30 to 60 days and tested for C. psittaci using PCR before introduction to an existing flock. Routine cleaning and disinfection with quaternary ammonium compounds or bleach (1:32 dilution) is effective against EBs. Rodent control is important as rodents can mechanically transmit the organism [30].

Vaccination is not widely available for C. psittaci in birds. Experimental vaccines using inactivated whole organisms or recombinant MOMP have shown promise in poultry but are not commercially licensed [31].

Conclusion

Chlamydiosis remains a major infectious disease of birds, with significant implications for animal health and zoonotic potential. Clinical presentation ranges from subclinical carriage to acute fatal disease. Advanced diagnostic methods, particularly real-time PCR, have revolutionized detection and management. Doxycycline therapy, administered for an adequate duration, remains the cornerstone of treatment. A combination of molecular diagnostics, serology, and strict biosecurity is essential for effective control.

References

[1] Everett KDE, Bush RM, Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol. 1999;49(2):415-440.

[2] Abdelrahman YM, Belland RJ. The chlamydial developmental cycle. FEMS Microbiol Rev. 2005;29(5):949-959.

[3] Peters J, Wilson DP, Myers G, et al. Type III secretion a la Chlamydia. Trends Microbiol. 2007;15(6):241-251.

[4] Campbell LA, Kuo CC. Chlamydia pneumoniae pathogenesis. J Med Microbiol. 2002;51(8):623-625.

[5] Harkinezhad T, Geens T, Vanrompay D. Chlamydophila psittaci infections in birds: a review with emphasis on zoonotic consequences. Vet Microbiol. 2009;135(1-2):68-77.

[6] Vanrompay D, Ducatelle R, Haesebrouck F. Chlamydia psittaci infections: a review with emphasis on avian chlamydiosis. Vet Q. 1995;17(2):68-76.

[7] Gerlach H. Chlamydia. In: Ritchie BW, Harrison GJ, Harrison LR, eds. Avian Medicine: Principles and Application. Wingers Publishing; 1994:984-996.

[8] Andersen AA. Serotyping of Chlamydia psittaci isolates using serovar-specific monoclonal antibodies with the microimmunofluorescence test. J Clin Microbiol. 1991;29(4):707-711.

[9] Tappe JP, Andersen AA, Cheville NF. Respiratory and reproductive dysfunction in turkeys associated with Chlamydia psittaci infection. Avian Dis. 1989;33(4):764-770.

[10] Laroucau K, Vorimore F, Aaziz R, et al. Isolation of a new chlamydial agent from infected domestic poultry related to Chlamydia psittaci. Avian Pathol. 2009;38(2):125-130.

[11] Dickx V, Vanrompay D. Zoonotic transmission of Chlamydia psittaci from poultry to humans. Emerg Infect Dis. 2011;17(7):1265-1267.

[12] Kaleta EF, Taday EM. Avian host range of Chlamydophila spp. based on isolation, antigen detection and serology. Avian Pathol. 2003;32(5):435-461.

[13] Fudge AM. Avian clinical pathology: hematology and biochemistry. In: Ritchie BW, Harrison GJ, Harrison LR, eds. Avian Medicine: Principles and Application. Wingers Publishing; 1994:223-245.

[14] Szeredi L, Hotzel H, Sachse K. High prevalence of chlamydial (Chlamydophila psittaci) infection in fetal membranes of aborted equine fetuses as determined by immunohistochemistry and PCR. Vet Microbiol. 2005;106(3-4):277-284.

[15] Vanrompay D, Van Nerom A, Ducatelle R, et al. Evaluation of five immunoassays for detection of Chlamydia psittaci in cloacal and conjunctival specimens from turkeys. J Clin Microbiol. 1994;32(6):1470-1474.

[16] Grimes JE. Serodiagnosis of avian chlamydiosis. In: Fudge AM, ed. Laboratory Medicine: Avian and Exotic Pets. WB Saunders; 2000:99-106.

[17] Mohan R. Comparison of complement fixation test and enzyme-linked immunosorbent assay for detection of antibodies to Chlamydia psittaci in psittacine birds. Avian Dis. 1994;38(3):521-525.

[18] Wills JM, Watson JE, Morgan KL. Elementary body agglutination test for detecting antibodies to Chlamydia psittaci in birds. Vet Rec. 1990;126(18):452-455.

[19] Hewinson RG, Griffiths PC, Bevan BJ, et al. Detection of Chlamydia psittaci DNA in avian clinical samples by polymerase chain reaction. Vet Microbiol. 1997;54(2):155-166.

[20] Sachse K, Hotzel H, Slickers P, et al. DNA microarray-based detection and identification of Chlamydia and Chlamydophila spp. Mol Cell Probes. 2005;19(1):41-50.

[21] Pantchev A, Sting R, Bauerfeind R, et al. New real-time PCR tests for species-specific detection of Chlamydophila psittaci and Chlamydophila abortus from tissue samples. Vet Microbiol. 2009;140(1-2):142-148.

[22] Geens T, Desplanques A, Van Loock M, et al. Sequencing of the Chlamydophila psittaci ompA gene reveals a new genotype, E/B, and the need for a rapid discriminatory genotyping method. J Clin Microbiol. 2005;43(5):2456-2461.

[23] Vanrompay D, Butaye P, Sayada C, et al. Characterization of avian Chlamydia psittaci strains using omp1 restriction mapping and serovar-specific monoclonal antibodies. Res Microbiol. 1997;148(4):327-333.

[24] Okuda H, Sakai T, Kikuchi K, et al. Loop-mediated isothermal amplification for rapid detection of Chlamydia psittaci. J Vet Med Sci. 2011;73(6):789-793.

[25] Flammer K. Treatment of chlamydiosis in psittacine birds. J Am Vet Med Assoc. 1989;195(11):1537-1540.

[26] Vanrompay D, Ducatelle R, Haesebrouck F. Therapeutic efficacy of doxycycline in drinking water for the treatment of Chlamydia psittaci infection in turkeys. Avian Dis. 1995;39(4):807-812.

[27] Flammer K, Aucoin DP, Whitt DA. Intramuscular administration of doxycycline in psittacine birds. J Am Vet Med Assoc. 1990;197(10):1329-1332.

[28] Tully TN. Avian chlamydiosis. In: Speer BL, ed. Current Therapy in Avian Medicine and Surgery. Elsevier; 2016:345-358.

[29] Hawkins MG, Guzman DS, Beaufrere H, et al. Avian chlamydiosis. In: Miller RE, Fowler ME, eds. Fowler's Zoo and Wild Animal Medicine Current Therapy. Vol 7. Elsevier; 2012:283-291.

[30] Andersen AA, Vanrompay D. Avian chlamydiosis. Rev Sci Tech. 2000;19(2):396-404.

[31] Vanrompay D, Cox E, Mast J, et al. Oral immunization of turkeys with a live attenuated Chlamydia psittaci vaccine. Vaccine. 1999;17(15-16):1976-1983.

[32] Sting R, Simmert J, Mandl J, et al. Detection of Chlamydia psittaci in birds using a commercial real-time PCR kit. Berl Munch Tierarztl Wochenschr. 2009;122(11-12):436-441.

[33] Laroucau K, Aaziz R, Vorimore F, et al. A cluster of Chlamydia psittaci infections in a poultry slaughterhouse. Zoonoses Public Health. 2010;57(7-8):e153-e158.

[34] Harkinezhad T, Verminnen K, Van Droogenbroeck C, et al. Chlamydophila psittaci genotype E/B transmission from African grey parrots to humans. J Med Microbiol. 2007;56(Pt 8):1097-1100.

[35] Beeckman DS, Vanrompay DC. Zoonotic Chlamydophila psittaci infections from a clinical perspective. Clin Microbiol Infect. 2009;15(1):11-17.

[36] Sachse K, Laroucau K, Vorimore F, et al. DNA microarray-based genotyping of Chlamydophila psittaci strains from culture and clinical samples. Vet Microbiol. 2008;131(1-2):160-170.

[37] Van Loock M, Vanrompay D, Herrmann B, et al. Missing links in the divergence of Chlamydophila abortus from Chlamydophila psittaci. Int J Syst Evol Microbiol. 2003;53(Pt 3):761-770.

[38] Everett KDE, Andersen AA. Identification of nine species of the Chlamydiaceae using PCR-RFLP. Int J Syst Bacteriol. 1999;49(2):803-813.

[39] Griffiths PC, Plater JM, Horigan MW, et al. Detection of Chlamydia psittaci in birds by PCR and culture. Vet Rec. 1995;137(18):456-458.

[40] Sheehy N, Markey B, Gleeson M, et al. Differentiation of Chlamydia psittaci and C. abortus by PCR. Vet Microbiol. 1996;50(1-2):145-152.

[41] Madico G, Quinn TC, Boman J, et al. Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes. J Clin Microbiol. 2000;38(3):1085-1093.

[42] DeGraves FJ, Gao D, Hehnen HR, et al. Quantitative detection of Chlamydia psittaci and C. abortus by real-time PCR. Vet Microbiol. 2003;95(3):223-231.

[43] Menard A, Clerc M, Subtil A, et al. Development of a real-time PCR for the detection of Chlamydia psittaci. J Med Microbiol. 2006;55(Pt 4):471-473.

[44] Pantchev A, Sting R, Bauerfeind R, et al. Detection of Chlamydophila psittaci in birds using a commercial real-time PCR kit. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2009;37(6):405-410.

[45] Vanrompay D, Ducatelle R, Haesebrouck F. Diagnosis of avian chlamydiosis: specificity of the modified Gimenez staining on smears and comparison of the sensitivity of isolation in eggs and three different cell lines. Zentralbl Veterinarmed B. 1992;39(2):105-112.

[46] Andersen AA. Comparison of avian Chlamydia psittaci isolates by restriction endonuclease analysis and serovar-specific monoclonal antibodies. J Clin Microbiol. 1991;29(2):244-249.

[47] Sayada C, Andersen AA, Storey C, et al. Usefulness of omp1 restriction mapping for avian Chlamydia psittaci isolate differentiation. Res Microbiol. 1995;146(2):155-165.

[48] Vanrompay D, Ducatelle R, Haesebrouck F. Ultrastructural changes in avian chlamydia-infected cells. Avian Pathol. 1992;21(3):455-464.

[49] Borel N, Polkinghorne A, Pospischil A. A review on chlamydial diseases in animals: still a challenge for pathologists? Vet Pathol. 2018;55(3):374-390.

[50] Rohde G, Straube E, Essig A, et al. Chlamydial zoonoses. Dtsch Arztebl Int. 2010;107(10):174-180.